In a landmark cardiovascular outcomes trial, semaglutide demonstrated a reduction in major adverse cardiovascular events, such as heart attack, stroke, and cardiovascular death, in patients with type 2 diabetes
However, it is not suitable for everyone
Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams
What we know Research studies investigating the impact of vitamin D supplementation in individuals with heart failure is at a very early stage In one randomized controlled trial, vitamin D supplementation (1,200 IU/day for 12 weeks) improved heart muscle performance in children with CHF
Skip to content What are the Benefits of Retatrutide Treatment